CN1318052C - 一种治疗痤疮的药物组合物及制备方法 - Google Patents
一种治疗痤疮的药物组合物及制备方法 Download PDFInfo
- Publication number
- CN1318052C CN1318052C CNB021461767A CN02146176A CN1318052C CN 1318052 C CN1318052 C CN 1318052C CN B021461767 A CNB021461767 A CN B021461767A CN 02146176 A CN02146176 A CN 02146176A CN 1318052 C CN1318052 C CN 1318052C
- Authority
- CN
- China
- Prior art keywords
- radix
- weight portion
- extract
- ethanol
- radix angelicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 36
- 206010000496 acne Diseases 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 title claims description 36
- 238000000034 method Methods 0.000 title claims description 17
- 229940079593 drug Drugs 0.000 title description 25
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000008187 granular material Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 8
- 241000207929 Scutellaria Species 0.000 claims abstract description 3
- 241000555682 Forsythia x intermedia Species 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 71
- 239000000284 extract Substances 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000008194 pharmaceutical composition Substances 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- 239000002671 adjuvant Substances 0.000 claims description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 12
- 238000004064 recycling Methods 0.000 claims description 12
- 238000001291 vacuum drying Methods 0.000 claims description 12
- 238000002481 ethanol extraction Methods 0.000 claims description 11
- 239000000341 volatile oil Substances 0.000 claims description 11
- 238000003809 water extraction Methods 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- 239000001116 FEMA 4028 Substances 0.000 claims description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 4
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 4
- 229960004853 betadex Drugs 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 238000001256 steam distillation Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 210000002784 stomach Anatomy 0.000 abstract description 12
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 238000007792 addition Methods 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000002496 gastric effect Effects 0.000 description 10
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 229930003944 flavone Natural products 0.000 description 6
- 235000011949 flavones Nutrition 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 241000721047 Danaus plexippus Species 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 201000004700 rosacea Diseases 0.000 description 5
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 4
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241001303601 Rosacea Species 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 150000003797 alkaloid derivatives Chemical group 0.000 description 4
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 4
- 150000004056 anthraquinones Chemical class 0.000 description 4
- 150000002213 flavones Chemical class 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 229930014456 matrine Natural products 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 229930183118 Tanshinone Natural products 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000000051 antiandrogen Substances 0.000 description 3
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 3
- 229960003321 baicalin Drugs 0.000 description 3
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- -1 benzoyl benzyl ester Chemical class 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- JJVGFDTWFVSBIM-UHFFFAOYSA-N Phillyrin Natural products COc1ccc(cc1OC)C2OCC3C2COC3c4ccc(OC)c(OC5OC(CO)C(O)C(O)C5O)c4 JJVGFDTWFVSBIM-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010039705 Scleritis Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 239000000890 drug combination Substances 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229960005280 isotretinoin Drugs 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 229930015582 oxymatrine Natural products 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- PRYXPGFZVGZNBL-ADLFWFRXSA-N salviol Chemical compound CC(C)c1cc2CC[C@H]3C(C)(C)C[C@H](O)C[C@]3(C)c2cc1O PRYXPGFZVGZNBL-ADLFWFRXSA-N 0.000 description 2
- AJSGWTLZEUBGFV-UHFFFAOYSA-N salviol Natural products CC(C)c1cc2CCC3C(CC(O)CC3(C)C)c2cc1O AJSGWTLZEUBGFV-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010048810 Sebaceous hyperplasia Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229930195208 isotanshinone Natural products 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021461767A CN1318052C (zh) | 2002-11-01 | 2002-11-01 | 一种治疗痤疮的药物组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021461767A CN1318052C (zh) | 2002-11-01 | 2002-11-01 | 一种治疗痤疮的药物组合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1418674A CN1418674A (zh) | 2003-05-21 |
CN1318052C true CN1318052C (zh) | 2007-05-30 |
Family
ID=4751018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021461767A Expired - Lifetime CN1318052C (zh) | 2002-11-01 | 2002-11-01 | 一种治疗痤疮的药物组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1318052C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1302788C (zh) * | 2005-11-04 | 2007-03-07 | 山东师范大学 | 一种治疗粉刺的外用药液及其制备方法 |
CN102908411A (zh) * | 2012-11-21 | 2013-02-06 | 安文娟 | 一种治疗痤疮的药膏 |
CN103432244B (zh) * | 2013-09-11 | 2016-01-20 | 余红波 | 一种具有祛痘功能的组合物 |
CN103655416B (zh) * | 2013-11-26 | 2015-05-06 | 郑州高尚生物科技有限公司 | 一种多效祛痘美容霜及其制备方法 |
CN110694015A (zh) * | 2019-10-09 | 2020-01-17 | 江苏省中医院 | 一种祛痘凝胶及其制备方法 |
CN111939095A (zh) * | 2020-09-07 | 2020-11-17 | 云南洛蔻苏生物科技有限公司 | 一种皮肤修护液及其制备方法 |
CN111956742A (zh) * | 2020-09-07 | 2020-11-20 | 云南洛蔻苏生物科技有限公司 | 一种祛痘祛斑组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259382A (zh) * | 1999-12-16 | 2000-07-12 | 傅广和 | 连翘银花(液)冲剂 |
-
2002
- 2002-11-01 CN CNB021461767A patent/CN1318052C/zh not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259382A (zh) * | 1999-12-16 | 2000-07-12 | 傅广和 | 连翘银花(液)冲剂 |
Non-Patent Citations (1)
Title |
---|
中医药治疗痤疮的研究进展 鲁美君等,中医药信息,第18卷第3期 2001 * |
Also Published As
Publication number | Publication date |
---|---|
CN1418674A (zh) | 2003-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN102697830B (zh) | 一种防治经期疾病的药物组合物及其制备方法和应用 | |
CN102205026A (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN101502588B (zh) | 一种美容祛痘组合物及其制备方法 | |
CN101411782B (zh) | 一种治疗急性咽炎的药物组合物及其制备方法 | |
CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
CN104288609A (zh) | 一种治疗胃火炽盛型牙龈炎的中药组合物及其制备方法 | |
CN101569739B (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN104740583B (zh) | 一种用于缓解克罗恩病的中药制剂及其制备方法 | |
CN1318052C (zh) | 一种治疗痤疮的药物组合物及制备方法 | |
CN109288910A (zh) | 一种治疗妇科阴道炎的中药清洗液及其制备方法 | |
CN107998242A (zh) | 一种治疗奶牛乳房炎的中药组合物及其制备方法 | |
CN103735695A (zh) | 一种治疗尿路感染的中药组合物及其制备方法 | |
CN104940752A (zh) | 一种治疗外阴溃疡的中药制剂及其制备方法 | |
CN104740405B (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 | |
CN104042923A (zh) | 一种祛除青春痘的外用涂剂 | |
CN103479915B (zh) | 一种治疗急性肾炎的中药组合物及其制备方法 | |
CN109172732A (zh) | 一种抗hpv的中药组合物及其制备方法与应用 | |
CN103585366A (zh) | 一种治疗缺血性高脂血症的药物及其制备方法 | |
CN107213343A (zh) | 一种含白及的口腔溃疡中药药膏及其制备方法 | |
CN108143944A (zh) | 一种治疗伤风的中药组合物 | |
CN100438890C (zh) | 一种组织缺损原位再生膏剂 | |
CN105169152A (zh) | 一种皮肤止痒洗液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING TIANHENG HOSPITAL MANAGEMENT CO., LTD. Free format text: FORMER OWNER: BEIJING TIANHENG MEDICINE INST. Effective date: 20150114 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100039 FENGTAI, BEIJING TO: 100070 FENGTAI, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150114 Address after: 100070, room 25, building 188, No. eighteen, 407 West Fourth Ring Road, Fengtai District, Beijing Patentee after: Beijing Tianheng Drug Research Institute Address before: 100039 Beijing City, Fengtai District Jiang Jia Fen Road No. 329 Beijing Tianheng Pharmaceutical Institute Patentee before: TEAM ACADEMY OF PHARMACEUTICAL SCIENCE |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170511 Address after: 100141 Beijing city Fengtai District Xiaotun Road No. 8 purple Park office block C C510 Patentee after: Beijing Tianheng Drug Research Institute Address before: 100070, room 25, building 188, No. eighteen, 407 West Fourth Ring Road, Fengtai District, Beijing Patentee before: Beijing Tianheng Drug Research Institute |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200525 Address after: 135000 room 310, e-commerce building, 517-57 Kangmei Avenue, Meihekou City, Jilin Province Patentee after: Jilin Tianheng Kangtai Biotechnology Co.,Ltd. Address before: 100141 Beijing city Fengtai District Xiaotun Road No. 8 purple Park office block C C510 Patentee before: Beijing Tianheng Drug Research Institute |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20070530 |